A deuterated analog of dasatinib disrupts cell cycle progression and displays anti-non-small cell lung cancer activity in vitro and in vivo.

MLA

Ling, Chunhua, et al. “A Deuterated Analog of Dasatinib Disrupts Cell Cycle Progression and Displays Anti-Non-Small Cell Lung Cancer Activity in Vitro and in Vivo.” International Journal of Cancer, vol. 131, no. 10, Nov. 2012, pp. 2411–19. EBSCOhost, https://doi.org/10.1002/ijc.27504.

APA

Ling, C., Chen, G., Chen, G., Zhang, Z., Cao, B., Han, K., Yin, J., Chu, A., Zhao, Y., & Mao, X. (2012). A deuterated analog of dasatinib disrupts cell cycle progression and displays anti-non-small cell lung cancer activity in vitro and in vivo. International Journal of Cancer, 131(10), 2411–2419. https://doi.org/10.1002/ijc.27504

Chicago

Ling, Chunhua, Gang Chen, Guodong Chen, Zubin Zhang, Biyin Cao, Kunkun Han, Jianming Yin, Alex Chu, Yun Zhao, and Xinliang Mao. 2012. “A Deuterated Analog of Dasatinib Disrupts Cell Cycle Progression and Displays Anti-Non-Small Cell Lung Cancer Activity in Vitro and in Vivo.” International Journal of Cancer 131 (10): 2411–19. doi:10.1002/ijc.27504.